Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3369-3378

  Lukacher, Aron E ^a   Moser, Janice M ^a   Hadley, Annette ^a   Altman, John D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CD8 ANTIGEN; EPITOPE; MT389 397 RESTRICTED PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG; VIRUS MIDDLE T ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MEMORY CELL; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TUMOR RESISTANCE;

ACUTE DISEASE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GRAFT REJECTION; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PAPILLOMAVIRUS INFECTIONS; PEPTIDE FRAGMENTS; POLYOMAVIRUS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TUMOR VIRUS INFECTIONS;

EID: 0033568287     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Masucci, M. G. 1993. Viral immunopathology of human tumors. Curr. Opin. Immunol. 5:693.
2. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
3. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405.
4. Keating, P. J., F. V. Cromme, M. Duggan-Keen, P. J. F. Snijders, J. M. M. Walboomers, R. D. Hunter, P. A. Dyer, and P. L. Stem. 1995. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer 72:405.
5. Levitskaya, J., A. Sharipo, A. Leonchiks, A. Ciechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin/proteosome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen I. Proc. Natl. Acad. Sci. USA 94:12616.
6. Dawe, C. J., R. Freund, G. Mandel, K. Ballmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice: characterization of wild type strains with widely differing tumor profiles. Am. J Pathol. 127:243.
7. Berebbi, M., L. Dandolo, J. Hassoun, A. M. Bernard, and D. Blangy. 1988. Specific tissue targeting of polyoma virus oncogenicity in athymic nude mice. Oncogene 2:149.
8. Freund, R., T. Dubensky, R. Bronson, A. Sotkinov, J. Carroll, and T. Benjamin. 1992. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 191:724.
9. Wirth, J. J., L. G. Martin, and M. M. Fluck. 1997. Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential. J. Virol. 71:1072.
10. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683.
11. k-restricted epitope in the middle T protein. J. Immunol. 160:1724.
12. Brodsky, J. L., and J. M. Pipas. 1998. Polyomavirus T antigens: molecular chaperones for multiprotein complexes. J. Virol. 72:5329.
13. Raptis, L., H. Lamfrom, and T. L. Benjamin. 1985. Regulation of cellular phenotype and expression of polyoma virus middle T antigen in rat fibroblasts. Mol. Cell. Biol. 5:2476.
14. Freund, R., A. Sotnikov, R. T. Bronson, and T. L. Benjamin. 1992. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191:716.
15. Garcea, R. L., D. A. Talmage, A. Harmatz, R. Freund, and T. L. Benjamin. 1989. Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology 168:312.
16. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
17. + T cells. Science 280:227.
18. McMichael, A. J., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367.
19. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
20. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.
21. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827.
22. Ward, P. L., H. Koeppen, T. Hurteau, and H. Schreiber. 1989. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170:217.
23. Wilson, C. S., J. M. Moser, J. D. Altman, P. E. Jensen, and A. E. Lukacher. 1999. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL. J. Immunol. 162:3933.
24. 2-Microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252:275.
25. + T-cell-dependent surveillance. Cancer Res. 50:3851.
26. De Bergeyck, V., E. De Plaen, P. Chomez, T. Boon, and A. Van Pel. 1994. An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur. J. Immunol. 24:2203.
27. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
28. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
29. + memory T cells. J. Exp. Med. 186:859.
30. + T cells during an acute virus infection. Immunity 8:167.
31. a-reactive Vβ domains. Eur. J. Immunol. 22:291.
32. + T cells in primary and secondary influenza pneumonia. Immunity 8:683.
33. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
34. Testi, R., A. D'Ambrosia, R. DeMaria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15: 479.
35. Craston, R., M. Koh, A. Mc Dermott, N. Ray, H. G. Prentice, and M. W. Lowdell. 1997. Temporal dynamics of CD69 expression on lymphoid cells. J. Immunol. Methods 209:37.
36. Gross, L. G. 1983. The polyoma virus. In Oncogenic Viruses. 3rd Ed., Vol. 2. Pergamon Press, New York, p. 737.
37. Lukacher, A. E. 1999. Polyomavirus. In Persistent Viral Infections. R. Ahmed and I. Chen, eds. John Wiley & Sons, New York, p. 117.
38. Rooney, C. M., C. A. Smith, C. Y. C. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9.
39. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1780.
40. Ogg, G. S., X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, et al. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:797.
41. Talmage, D. A., R. Freund, T. Dubensky, M. Salcedo, P. Gariglio, L. M. Rangel, C. J. Dawe, and T. L. Benjamin. 1992. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology 187:734.
42. Selin, L. K., and R. M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of infectious virus. J. Immunol. 158:5366.
43. Opferman, J. T., B. T. Ober, and P. G. Ashton-Rickardt. 1999. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283:1745.
44. Gately, M. K., A. G. Wolitzky, P. M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143: 127.
45. + T lymphocytes. J. Immunol. 151:2444.
46. Salcedo, T. W., L. Azzoni, S. F. Wolf, and B. Perussia. 1993. Modulation of perform and granzyme messenger RNA expression in human natural killer cells. J. Immunol. 151:2511.
47. Rabinowich, H., R. B. Herberman, and T. L. Whiteside. 1993. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell. Immunol. 152:481.
48. Bloom, E. T., and J. A. Horvath. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. J. Immunol. 152:4242.
49. Casanova, J.-L., P. Romero, C. Widmann, P. Kourilsky, and J. L. Maryanski. 1991. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium burghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174:1371.
50. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Anna. Rev. Cell Biol. 9:101.
51. + T cells. J. Exp. Med. 185:641.
52. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675.
53. Busch, D. H., and E. G. Pamer. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701.
54. Kos, F. J., and E. G. Engleman 1996. Immune regulation: a critical link between NK cells and CTLs. Immunol. Today 17:174.
55. Medzhitov, R., and C. A. Janeway, Jr. 1998. Innate immune recognition and control of adaptive immune responses. Semin. Immunol. 10:351.
56. Biron, C. A. 1998. Role of early cytokines, including a and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383.
57. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429.